No image available for this title

LITERATURE

Comparison of Cefdinir and Cefaclor in Treatment of Community-Acquired Pneumonia


Six hundred ninety patients were enrolled in a multicenter, randomized, double-blind trial comparing the
efficacy and safety of cefdinir with those of cefaclor in the treatment of community-acquired pneumonia.
Patients received either 10 days of treatment with cefdinir (n 5 347) at 300 mg twice daily or 10 days of
treatment with cefaclor (n 5 343) at 500 mg three times daily. Microbiological assessments were performed on
sputum specimens obtained at admission and at the two posttherapy visits, if available


Availability

Omnicef-006Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1997, p. 1579–1583
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous